We found that the serum levels of resistin were increased with increasing GOLD stage in patients with COPD and significantly correlated with pulmonary function, clinical symptoms, nutritional status, and exercise tolerance. This evidence concerns the gene RETN and chronic obstructive pulmonary disease.